Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
80.38
+0.91 (1.15%)
Dec 5, 2025, 4:00 PM EST - Market closed
Monopar Therapeutics Employees
As of December 31, 2024, Monopar Therapeutics had 16 total employees, including 14 full-time and 2 part-time employees. The number of employees increased by 6 or 60.00% compared to the previous year.
Employees
16
Change (1Y)
6
Growth (1Y)
60.00%
Revenue / Employee
n/a
Profits / Employee
-$1,215,107
Market Cap
537.15M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MNPR News
- 22 days ago - Monopar Therapeutics Reports Third Quarter 2025 Financial Results and Recent Developments - GlobeNewsWire
- 26 days ago - Monopar Presents New Data and Analyses on Rapidly Improved Copper Balance in Wilson Disease Patients on Tiomolybdate Choline at AASLD - The Liver Meeting® 2025 - GlobeNewsWire
- 7 weeks ago - Monopar Announces Abstract Accepted for Oral Presentation at AASLD - The Liver Meeting® 2025 - GlobeNewsWire
- 2 months ago - Monopar Therapeutics Inc. Announces Pricing of $135 Million Underwritten Offering of Common Stock and Pre-Funded Warrants - GlobeNewsWire
- 2 months ago - Monopar Announces Journal of Hepatology Publishes Physicians' Letter to the Editor Demonstrating ALXN1840 Rapidly Improved Copper Balance in Wilson Disease Patients - GlobeNewsWire
- 2 months ago - Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting - GlobeNewsWire
- 3 months ago - Monopar Therapeutics: A Speculative Buy On 2 Fronts With Catalysts Imminent - Seeking Alpha
- 3 months ago - Monopar Announces Abstract Accepted with Distinction for Oral and Poster Presentations at the Upcoming American Neurological Association 2025 Annual Meeting - GlobeNewsWire